7 Best Biotech Stocks to Build Your Portfolio

Investing in biotech stocks can be tricky due to their volatile nature. That's why we turned to Wall Street's pros to find these top-rated picks.

atomic molecular structure with blue background
(Image credit: Getty Images)

Biotech stocks were some of the best performers at the start of the pandemic. More recently, though, they've vastly underperformed the broader market.

Case in point: In 2021, the SPDR S&P Biotech (XBI) lost 20.5%, compared to the S&P 500's 26.9% gain. And in 2022, the XBI is currently down 27.1%, while the S&P 500 has lost 10.4%.


Data is as of April 25. Dividend yields are calculated by annualizing the most recent payout and dividing by the share price.

To continue reading this article
please register for free

This is different from signing in to your print subscription

Why am I seeing this? Find out more here

Jaimini Desai
Contributing Writer, Kiplinger.com

Jaimini Desai has been a financial writer and reporter for nearly a decade. He has helped countless investors take profitable rides on some of the hottest growth trends. His previous experience includes writing for Investopedia, Seeking Alpha and MT Newswires.

He is the Chief Growth Strategist for StockNews.com and the editor of the POWR Growth and POWR Stocks Under $10 newsletters.